Your browser doesn't support javascript.
loading
Sequential loss of B-cell target antigens in multiply relapsed high-grade B-cell lymphoma treated with targeted therapies.
Mian, Agrima; Bhattarai, Narendra; Sheu, Michael; Ondrejka, Sarah L; Caimi, Paolo F; Hill, Brian T.
Afiliação
  • Mian A; Department of Internal Medicine, Taussig Cancer Institute, Cleveland, Ohio, USA.
  • Bhattarai N; Robert J. Tomsich Pathology & Laboratory Medicine Institute, Taussig Cancer Institute, Cleveland, Ohio, USA.
  • Sheu M; Department of Internal Medicine, Taussig Cancer Institute, Cleveland, Ohio, USA.
  • Ondrejka SL; Robert J. Tomsich Pathology & Laboratory Medicine Institute, Taussig Cancer Institute, Cleveland, Ohio, USA.
  • Caimi PF; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland, Ohio, USA.
  • Hill BT; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland, Ohio, USA.
Br J Haematol ; 198(5): e71-e74, 2022 09.
Article em En | MEDLINE | ID: mdl-35733291

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Linfoma de Células B Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Linfoma de Células B Idioma: En Ano de publicação: 2022 Tipo de documento: Article